Anixa Biosciences (ANIX) Enterprise Value Growth (5y) (2015 - 2026)
Anixa Biosciences (ANIX) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 6.83% |
| Oct 31, 2025 | -25.98% |
| Jul 31, 2025 | -12.51% |
| Apr 30, 2025 | -15.08% |
| Jan 31, 2025 | -15.85% |
| Oct 31, 2024 | -36.67% |
| Jul 31, 2024 | -36.52% |
| Apr 30, 2024 | -46.19% |
| Jan 31, 2024 | -47.55% |
| Oct 31, 2023 | -55.08% |
| Jul 31, 2023 | -54.63% |
| Apr 30, 2023 | -55.10% |
| Jan 31, 2023 | -38.90% |
| Oct 31, 2022 | -47.45% |
| Jul 31, 2022 | -39.77% |
| Apr 30, 2022 | -45.12% |
| Jan 31, 2022 | -77.51% |
| Oct 31, 2021 | -62.24% |
| Jul 31, 2021 | -56.63% |
| Apr 30, 2021 | -52.02% |